UBS Bets on Target's $2B Turnaround Plan for 2026 Outlook
UBS analysts view Target's planned $2 billion investment for 2026 as a bold, two-pronged turnaround bet. The plan spl...
Uncover the best credit cards for travel rewards that can enhance your travel experience. Start exploring today.
15,143 articlesUBS analysts view Target's planned $2 billion investment for 2026 as a bold, two-pronged turnaround bet. The plan spl...
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
CrowdStrike forms a strategic tie-up with Nebius Group to integrate Falcon security into Nebius AI Cloud, while repor...
Playnance launches the G Coin presale on March 18, positioning the token as the utility layer for an ecosystem with h...
A rising fintech stock year story shows profits climbing while a major fund trims nearly $300M from its stake. The mo...
A sharp one-week drop surprised many investors. This analysis explains the drivers behind the decline, from KPI discl...
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
A federal jury awarded $3 million to a woman in the first-ever social media addiction trial against Meta and Google, ...
What looks like a bargain today could turn into a meaningful gain by 2026. This guide shows how patient investors ide...
TON climbs from about $1.30 to $2.50 in three days as Telegram signals a major governance shift, slashing fees and ta...
As crypto markets shift into a new cycle, investors wonder where will chainlink (link) fit. This guide breaks down LI...
Eli Lilly is delivering big news for investors. The rallying force behind recent gains comes from GLP-1 drugs, manufa...